Marpai reports Q1 2023 net revenue $9.7M, operating loss $8.5M

Marpai, Inc.

2023-Q1 EPS reported -$0.42 revenue$9,672,045

Net revenue $9.7M for Q1 2023, up 26.8% sequentially from $7.6M in Q4 2022, driven by full quarter of Maestro Health.
Operating loss $8.5M; net loss $8.9M; adjusted negative EBITDA $6.7M.
Covered employees under administered health plans were 41,571 as of Mar 31, 2023, down from 42,107 at Dec 31, 2022.
Q1 2023 expenses included $1.5M for Value Based Care Platform and $0.8M for unused facilities and severance.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Marpai, Inc. reported first quarter ended March 31, 2023 results: revenue approximately $9.7 million, net income approximately $8.9 million.

Period: first quarter ended March 31, 2023
Revenue: approximately $9.7 million
Net income: approximately $8.9 million
Result: reported results

Exact text from the filing

all periods presented, and the results of Maestro Health, LLC (“Maestro Health”) since its acquisition on November 1, 2022. Financial Highlights • Net revenue of approximately $9.7 million for the three months ended March 31, 2023, compared to net revenue of approximately $7.6 million for the three months ended December 31, 2022, representing a sequential increase

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

Marpai, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-020636

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.